Georgia vs Kazakhstan: The number of people with susceptibility test result for rifampicin
Georgia
99.79
in 2021
Kazakhstan
99.88
in 2021
Georgia rank
33rd
Kazakhstan rank
32nd
The number of people with susceptibility test result for rifampicin over time
- Georgia
- Kazakhstan
How they compare
Kazakhstan currently reports 99.88 against 99.79 in Georgia, a difference of 0.09.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Georgia ahead.
Georgia ranks 33rd and Kazakhstan ranks 32nd of 146 countries.
Across the 2 decades both report, Georgia averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Georgia | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.27 | 82.55 | 15.72 | Georgia |
| 2020s | 99.8 | 99.9 | 0.0988 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Georgia or Kazakhstan?
- Kazakhstan, at 99.88 against 99.79 in Georgia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Georgia and Kazakhstan?
- 0.09, with Kazakhstan ahead.
- How many years of comparable data are there for Georgia and Kazakhstan?
- 5 years are reported by both, from 2017 to 2021.
- How do Georgia and Kazakhstan rank globally for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 33rd and Kazakhstan ranks 32nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.